2BB score and signals
Fennec Pharmaceuticals Inc.’s current 2BB score is 57 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 61 | High |
| Momentum | 61 | Improving |
| Financial strength | 39 | Weak |
| Quality | 60 | Strong |
| Risk | 43 | Moderate |
Company facts
| Headquarters | Durham, North Carolina, United States |
| Founded | 1996 |
| Employees | 35 |
| 52-week range | $5.65 – $13.25 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | 0.1014 | — | $19.31M |
| 2026-08-11 | 0.05 | 0.01 | $17.87M | $16.44M |
| 2026-05-14 | 0.01 | -0.0085 | $15.11M | $14.23M |
| 2026-03-24 | -0.1 | 0.0357 | $13.78M | $14.27M |
Related companies
